
Dasgupta offers more than 30 years of experience across diverse medtech markets globally. Notably, he spent three decades with Johnson & Johnson MedTech. Now, the veteran of the industry — and the region — comes to CMR to help drive operations around its surgical robot in the region.
Most recently, Dasgupta served as vice chair and global president at Shalby Limited, a healthcare group in India. There, he had responsibility for driving Shalby’s acquired orthopedic implant business, based in California. He also provided strategic oversight to the company’s base hospital business.
Dasgupta’s 30-year tenure at J&J MedTech included stints as a member of the J&J Orthopedics Global Board and Asia Pacific MedTech Leadership Team. His final two positions at J&J were managing director for J&J Medical India and VP of orthopedics for J&J Asia Pacific.
“Asia Pacific, the Middle East and Africa are some of the fastest growing markets in the world for surgical robotics and so we are pleased to welcome Sushobhan to CMR to oversee our commercial operations across these regions,” said Supratim Bose, CMR Surgical CEO. “His diverse experience working across various medtech industry markets and his strong reputation with surgeons and hospitals in the region will be a real asset to us. With new product launches and strong growth across the region, it’s the perfect time for him to join and help get the benefits of minimal access surgery to more patients.”
Bose recently spoke to MassDevice about the company’s future plans for growth. Read here.
About CMR Surgical and its Versius surgical robot
Versius, a small-scale surgical robotic system, features collaborative arms and bedside units for direct patient access. It also features offers of port placement to best suit the needs of each patient. CMR Surgical designed Versius to enable surgeons to perform more minimal access surgery. Its minimally invasive approach assists surgeons accessing the lungs, thymus and esophagus.
Recent highlights include the latest Versius installation in Germany, announced last month. That means there have been more than 140 around the world to date. Expansion over 2023 included new markets such as Greece and Indonesia. CMR Surgical also raised $165 million to support Versius in September.
The company says it charged new CCO Massimiliano Colella with leading the further acceleration of Versius installations in 2024. It also added new imaging tech to the platform earlier this month.
CMR Surgical said it closed the year with its Versius global install base more than 50% higher than in 2022. It reports more than 17,000 surgical procedures completed with Versius during the year for growth of more than 60%.
“Having worked in the MedTech sector for over three decades across Asia Pacific and the US, I am excited to be able to bring Versius, a truly differentiated product to hospitals and surgeons,” Dasgupta said. “There is strong demand for surgical robotics across Asia Pacific, the Middle East and Africa and working with the CMR team, we will continue to drive commercial success and most importantly help patients to get the best surgical care.”